Novel biomarkers for ovarian cancer diagnosis
Most patients with ovarian cancer present with metastases at the time of diagnosis, necessitating the identification of novel biomarkers for prompt diagnosis. The EU-funded KLKs4OvCa project will focus on kallikrein-related peptidases (KLKs), a family of enzymes that participate in a broad spectrum of biological processes. Since KLKs are upregulated in ovarian cancer and associated with dismal prognosis, scientists aim to unveil their role in the disease by investigating their activity. Project results will determine the prognostic and therapeutic value of these biomarkers and help address the challenge of prompt ovarian cancer diagnosis.